Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA).
Breccia M, Celant S, Olimpieri PP, Olimpieri OM, Pane F, Iurlo A, Cirilli A, Colatrella A, Gozzo L, Pugliese S, Summa V, Foggi P, Corradini P, Russo P; AIFA Monitoring Registries Group. Breccia M, et al. Among authors: gozzo l. Ann Hematol. 2021 Feb;100(2):481-485. doi: 10.1007/s00277-021-04406-1. Epub 2021 Jan 7. Ann Hematol. 2021. PMID: 33415425
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA).
Breccia M, Olimpieri PP, Olimpieri O, Pane F, Iurlo A, Foggi P, Cirilli A, Colatrella A, Cuomo M, Gozzo L, Summa V, Corradini P, Russo P; AIFA’s Monitoring Registries Group. Breccia M, et al. Among authors: gozzo l. Cancer Med. 2020 Jun;9(12):4160-4165. doi: 10.1002/cam4.3071. Epub 2020 Apr 22. Cancer Med. 2020. PMID: 32319737 Free PMC article.
Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries.
Olimpieri PP, Di Lenarda A, Mammarella F, Gozzo L, Cirilli A, Cuomo M, Gulizia MM, Colivicchi F, Murri G, Gabrielli D, Trotta F. Olimpieri PP, et al. Among authors: gozzo l. Int J Cardiol Heart Vasc. 2020 Jan 23;26:100465. doi: 10.1016/j.ijcha.2019.100465. eCollection 2020 Feb. Int J Cardiol Heart Vasc. 2020. PMID: 32021902 Free PMC article.
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD, Longo L, Mansueto S, Gozzo L, Barberi I, Tiralongo V, Salvo V, Falsaperla R, Vitaliti G, La Rosa M, Leonardi S, Rotondo A, Avola N, Sgarlata D, Damiano A, Tirantello M, Anzelmo G, Cipolla D, Rizzo A, Russo A, Ruggieri M, Salomone S, Drago F. Pratico AD, et al. Among authors: gozzo l. Curr Drug Saf. 2018;13(3):200-207. doi: 10.2174/1574886313666180619120406. Curr Drug Saf. 2018. PMID: 29921210
Pegylated Asparaginase-Induced Liver Injury: A Case-Based Review and Data From Pharmacovigilance.
Vetro C, Duminuco A, Gozzo L, Maugeri C, Parisi M, Brancati S, Longo L, Vitale DC, Romano GL, Ciuni R, Mauro E, Fiumara PF, Palumbo GAM, Drago F, Di Raimondo F. Vetro C, et al. Among authors: gozzo l. J Clin Pharmacol. 2022 Sep;62(9):1142-1150. doi: 10.1002/jcph.2052. Epub 2022 Apr 14. J Clin Pharmacol. 2022. PMID: 35342960 Review. No abstract available.
41 results